Category Archives: BMY

Below are the downside targets for Bristol-Myers Squibb (BMY) with precedence from prior periods to the present.  Additionally, we include Gould’s Altimeter for relatively consistent pattern since the early 1990’s. We believe that the data indicates highly probable targets for initiating research and purchases of BMY with a high level of  confidence and reduced risk.